Correction: ANK1 is up-regulated in laser captured microglia in Alzheimer’s brain; the importance of addressing cellular heterogeneity (PLoS ONE (2017) 12: 7 (e0177814) DOI: 10.1371/journal.pone.0177814);ANK1 is up-regulated in laser captured microglia in Alzheimer’s brain; the importance of addressing cellular heterogeneity

PLoS ONE

Volumn 12, Issue 7, 2017, Pages

  Mastroeni, Diego ^a,b   Sekar, Shobana ^c   Nolz, Jennifer ^a   Delvaux, Elaine ^a   Lunnon, Katie ^d   Mill, Jonathan ^d,e   Liang, Winnie S ^c   Coleman, Paul D ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ANK1 PROTEIN, HUMAN; ANKYRIN;

ABCA7 GENE; AGED; ALZHEIMER DISEASE; ANK1 GENE; ARTICLE; ASTROCYTE; BIN1 GENE; BRAIN HOMOGENATE; CDH23 GENE; CELL HETEROGENEITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIP2A GENE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCUS; HIPPOCAMPAL CA1 REGION; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MALE; MICROGLIA; RHBDF2 GENE; RNA SEQUENCE; RNF34 GENE; RPL13 GENE; SERPINF1 GENE; SERPINF2 GENE; UPREGULATION; CASE CONTROL STUDY; CYTOLOGY; FEMALE; GENETICS; HIPPOCAMPUS; METABOLISM; NERVE CELL; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANKYRINS; CASE-CONTROL STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MICROGLIA; NEURONS; RNA, MESSENGER; UP-REGULATION;

EID: 85023160642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0191382     Document Type: Erratum

References (31)

1. LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci. 2007; 8(7):499–509. https://doi.org/10.1038/nrn2168 PMID: 17551515.
2. Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders. Nat Rev Neurosci. 2007; 8(9):663–72. PMID: 17684513. https://doi.org/10.1038/ nrn2194
3. Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A. Neuroinflammation in Alzheimer’s disease and Parkinson’s disease: are microglia pathogenic in either disorder? Int Rev Neurobiol. 2007; 82:235–46. PMID: 17678964. https://doi.org/10.1016/S0074-7742(07)82012-5
4. Wyss-Coray T, Rogers J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med. 2013; 2(1):a006346. PMID: 22315714. https://doi.org/10.1101/cshperspect.a006346
5. Solito E, Sastre M. Microglia function in Alzheimer’s disease. Front Pharmacol. 3:14. PMID: 22363284. https://doi.org/10.3389/fphar.2012.00014
6. Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA. Neuroinflammation—an early event in both the history and pathogenesis of Alzheimer’s disease. Neurodegener Dis. 2010; 7(1–3):38–41. PMID: 20160456. https://doi.org/10.1159/000283480
7. Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol. 2013; 9(1):25–34. PMID: 23183882. https://doi.org/10.1038/nrneurol.2012.236
8. Rogers J, Webster S, Lue LF, Brachova L, Civin WH, Emmerling M, et al. Inflammation and Alzheimer’s disease pathogenesis. Neurobiol Aging. 1996; 17(5):681–6. PMID: 8892340.
9. Cuyvers E, Sleegers K. Genetic variations underlying Alzheimer’s disease: evidence from genome-wide association studies and beyond. Lancet Neurol. 2016; 15(8):857–68. https://doi.org/10.1016/ S1474-4422(16)00127-7 PMID: 27302364.
10. Voronin DA, Kiseleva EV. [Functional role of proteins containing ankyrin repeats]. Tsitologiia. 2007; 49 (12):989–99. PMID: 18318217.
11. De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, et al. Alzheimer’s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014; 17 (9):1156–63. https://doi.org/10.1038/nn.3786 PMID: 25129075; PubMed Central PMCID: PMCPMC4292795.
12. Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer’s disease. Nat Neurosci. 2014; 17(9):1164–70. https://doi.org/10.1038/nn.3782 PMID: 25129077; PubMed Central PMCID: PMCPMC4410018.
13. Chi S, Song JH, Tan MS, Zhang W, Wang ZX, Jiang T, et al. Association of Single-Nucleotide Polymorphism in ANK1 with Late-Onset Alzheimer’s Disease in Han Chinese. Mol Neurobiol. 2015. https://doi.org/10.1007/s12035-015-9547-x PMID: 26611832.
14. Imamura M, Maeda S, Yamauchi T, Hara K, Yasuda K, Morizono T, et al. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum Mol Genet. 2012; 21(13):3042–9. https://doi.org/10.1093/hmg/dds113 PMID: 22456796.
15. Harder MN, Ribel-Madsen R, Justesen JM, Sparso T, Andersson EA, Grarup N, et al. Type 2 diabetes risk alleles near BCAR1 and in ANK1 associate with decreased beta-cell function whereas risk alleles near ANKRD55 and GRB14 associate with decreased insulin sensitivity in the Danish Inter99 cohort. J Clin Endocrinol Metab. 2013; 98(4):E801–6. https://doi.org/10.1210/jc.2012-4169 PMID: 23457408.
16. Janson J, Laedtke T, Parisi JE, O’Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes. 2004; 53(2):474–81. PMID: 14747300.
17. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009; 25(9):1105–11. https://doi.org/10.1093/bioinformatics/btp120 PMID: 19289445; PubMed Central PMCID: PMC2672628.
18. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature protocols. 2012; 7(3):562–78. https://doi.org/10.1038/nprot.2012.016 PMID: 22383036; PubMed Central PMCID: PMC3334321.
19. Berchtold NC, Coleman PD, Cribbs DH, Rogers J, Gillen DL, Cotman CW. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer’s disease. Neurobiol Aging. 2013; 34(6):1653–61. https://doi.org/10.1016/j.neurobiolaging.2012.11.024 PMID: 23273601; PubMed Central PMCID: PMCPMC4022280.
20. Berchtold NC, Sabbagh MN, Beach TG, Kim RC, Cribbs DH, Cotman CW. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer’s disease. Neurobiol Aging. 2014; 35(9):1961–72. https://doi.org/10.1016/j.neurobiolaging.2014.03.031 PMID: 24786631; PubMed Central PMCID: PMCPMC4067010.
21. Zhao M, Finlay D, Zharkikh I, Vuori K. Novel Role of Src in Priming Pyk2 Phosphorylation. PLoS One. 2016; 11(2):e0149231. https://doi.org/10.1371/journal.pone.0149231 PMID: 26866924; PubMed Central PMCID: PMCPMC4750869.
22. Zhang Z, Chu SF, Mou Z, Gao Y, Wang ZZ, Wei GN, et al. Ganglioside GQ1b induces dopamine release through the activation of Pyk2. Mol Cell Neurosci. 2016; 71:102–13. https://doi.org/10.1016/j.mcn.2015.12.009 PMID: 26704905.
23. Vanarotti MS, Finkelstein DB, Guibao CD, Nourse A, Miller DJ, Zheng JJ. Structural Basis for the Interaction between Pyk2-FAT Domain and Leupaxin LD Repeats. Biochemistry. 2016; 55(9):1332–45. https://doi.org/10.1021/acs.biochem.5b01274 PMID: 26866573; PubMed Central PMCID: PMCPMC4843776.
24. Morbach H, Schickel JN, Cunningham-Rundles C, Conley ME, Reisli I, Franco JL, et al. CD19 controls Toll-like receptor 9 responses in human B cells. J Allergy Clin Immunol. 2016; 137(3):889–98 e6. https://doi.org/10.1016/j.jaci.2015.08.040 PMID: 26478008; PubMed Central PMCID: PMCPMC4783287.
25. Meng XQ, Dai YY, Jing LD, Bai J, Liu SZ, Zheng KG, et al. Subcellular localization of Pyk2 during oocyte fertilization and early-embryo development in mice. J Reprod Dev. 2016. https://doi.org/10.1262/jrd. 2016-015 PMID: 27086609.
26. Jin WJ, Kim B, Kim JW, Kim HH, Ha H, Lee ZH. Notch2 signaling promotes osteoclast resorption via activation of PYK2. Cell Signal. 2016; 28(5):357–65. https://doi.org/10.1016/j.cellsig.2016.01.016PMID: 26829213.
27. Giralt A, Coura R, Girault JA. Pyk2 is essential for astrocytes mobility following brain lesion. Glia. 2016; 64(4):620–34. https://doi.org/10.1002/glia.22952 PMID: 26663135.
28. Eleniste PP, Patel V, Posritong S, Zero O, Largura H, Cheng YH, et al. Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms. J Cell Bio-chem. 2016; 117(6):1396–406. https://doi.org/10.1002/jcb.25430 PMID: 26552846; PubMed Central PMCID: PMCPMC4821770.
29. Kulis M, Queiros AC, Beekman R, Martin-Subero JI. Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer. Biochim Biophys Acta. 2013; 1829(11):1161–74. https://doi.org/10.1016/j.bbagrm.2013.08.001 PMID: 23938249.
30. Lee SM, Choi WY, Lee J, Kim YJ. The regulatory mechanisms of intragenic DNA methylation. Epige-nomics. 2015; 7(4):527–31. https://doi.org/10.2217/epi.15.38 PMID: 26111026.
31. Rauscher GH, Kresovich JK, Poulin M, Yan L, Macias V, Mahmoud AM, et al. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation. BMC Cancer. 2015; 15:816. https://doi.org/10.1186/s12885-015-1777-9 PMID: 26510686; PubMed Central PMCID: PMCPMC4625569.